Postantibiotic effects of daptomycin against 14 staphylococcal and pneumococcal clinical isolates

G A Pankuch1, M R Jacobs, P C Appelbaum

  • 1Department of Pathology, Hershey Medical Center, Hershey, Pennsylvania 17033, USA.

Insights

Daptomycin exhibits significant postantibiotic effects (PAEs) against Staphylococcus and Streptococcus pneumoniae, lasting several hours even at sub-minimum inhibitory concentrations. These findings are crucial for optimizing daptomycin dosing regimens.

Area of Science:

  • Pharmacology and Microbiology
  • Antibiotic Resistance Studies

Background:

  • Daptomycin is a critical antibiotic for treating Gram-positive bacterial infections.
  • Understanding postantibiotic effects (PAEs) is essential for optimizing antibiotic therapy and combating resistance.

Purpose of the Study:

  • To quantify the postantibiotic effects (PAEs) of daptomycin against Staphylococcus species.
  • To determine the postantibiotic effects (PAEs) of daptomycin against Streptococcus pneumoniae.
  • To evaluate the sub-minimum inhibitory concentration (sub-MIC) effects of daptomycin on these bacteria.

Main Methods:

  • Bacterial cultures of Staphylococcus and Streptococcus pneumoniae were exposed to daptomycin.
  • Postantibiotic effects (PAEs) were measured by determining the duration of bacterial growth inhibition after antibiotic removal.
  • Sub-minimum inhibitory concentration (sub-MIC) effects were assessed at 0.4 times the minimum inhibitory concentration (MIC).

Main Results:

  • Mean staphylococcal PAEs ranged from 1.1 to 6.2 hours (mean 2.5 h).
  • Mean pneumococcal PAEs ranged from 1.0 to 2.5 hours (mean 1.7 h).
  • Sub-MIC effects for Staphylococcus and Streptococcus pneumoniae were prolonged, ranging from 3.0 to >12.0 hours and 1.9 to >12.0 hours, respectively.

Conclusions:

  • Daptomycin demonstrates substantial and prolonged postantibiotic effects against both Staphylococcus and Streptococcus pneumoniae.
  • Significant bacterial growth inhibition persists even at sub-minimum inhibitory concentrations, suggesting potential for extended dosing intervals.
  • These findings have implications for refining daptomycin treatment strategies to improve efficacy and manage bacterial resistance.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...